A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
about
Human polyomavirus reactivation: disease pathogenesis and treatment approachesMolecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainIntegrin-based therapeutics: biological basis, clinical use and new drugsMigration and pathogenicity of CD8 T cells in central nervous system diseasesPolyomavirus-Specific Cellular Immunity: From BK-Virus-Specific Cellular Immunity to BK-Virus-Associated Nephropathy?Animal Models for Progressive Multifocal LeukoencephalopathyThe importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathyMonitoring of pathogen-specific T-cell immune reconstitution after allogeneic hematopoietic stem cell transplantationProgressive multifocal leukoencephalopathy: new conceptsReal-time PCR in clinical microbiology: applications for routine laboratory testing.Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarateMonoclonal antibodies and progressive multifocal leukoencephalopathyReduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarateImproved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapyT cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donorsFunctional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disordersProgressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.Progressive multifocal leukoencephalopathy in HIV-1 infection.Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppressionImmune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation.Role of human leukocyte antigen class I alleles in progressive multifocal leukoencephalopathy.Trafficking of immune cells in the central nervous systemEmerging viral infections of the central nervous system: part 2Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab.Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rateLipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.Persistence and pathogenesis of the neurotropic polyomavirus JCInterplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology.Detection of JC virus-specific immune responses in a novel humanized mouse modelAsymptomatic reactivation of JC virus in patients treated with natalizumab.Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy.Immunological Markers for PML Prediction in MS Patients Treated with NatalizumabDeterminants of survival in progressive multifocal leukoencephalopathyPathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy.Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control.Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.
P2860
Q21285083-042A2BFF-5F9D-41D6-A8DA-596B4B250217Q24619923-1531B31D-666B-45F9-9A69-BF914074D5D7Q26773026-A2989A40-1C96-4882-A267-091BDA1E8BDAQ26784139-3AD9F946-84B3-4D28-8A1F-F2882990C03BQ26826085-A8BB7FDA-F794-4202-986C-7F313D6E3F70Q26853218-32B90AE7-5D85-4343-BAEA-1D0F3CD82EA0Q26859307-BA8E28C9-3AFA-4AF4-AC34-77CA1F4D366FQ26861648-07835D03-16F7-45C0-B3EB-E74E6A9AFC7CQ27016148-3ADC1293-583E-4C24-B772-841BEE1B3CF2Q27472851-6A55A7D3-514D-47A0-AF02-40F79A09AA18Q28083338-49412853-9E38-4D61-A000-374DF8DC9AB8Q28270413-67E3DD2D-6CFB-4C7B-9461-6680EE2C6EDEQ28388243-BE522EBB-4FAD-4913-8D53-D421681B8508Q28478894-27D06F41-1F40-4E74-9C6E-B7C267A17264Q28704590-0CBA1476-708E-4FB6-91FF-9BDDF646522DQ28740884-7EB2D74F-6961-4901-BAB4-B62456ABFC45Q30235523-400E74F8-BFB0-459E-ABF1-A601750B7AE9Q30245002-02244B9A-F6B4-4AAE-8CD4-FE789FB201B4Q33506561-6BFDA0CB-14A6-42E2-881B-9E66880E0BC2Q33510514-2E2FC13E-8E5D-4103-94C7-6627DB12A365Q33756663-FDF8DEE9-8ECE-480D-8E44-0D4D597645B7Q33789032-8C285C73-F5EF-4E9A-9365-1B10955B001CQ33815795-D25F8D5E-D104-4DFB-9678-2881D3C8139EQ33877744-B7B304E6-2F1C-4B1F-B2D2-5B6EA240725FQ33893285-82CBC669-CB12-4080-8DF6-FAD3FFDD47EEQ33930455-E7C77E52-7390-46EA-A96F-9ABAC4877349Q34132081-5D07DB31-F0DD-4728-9546-99198E7E9B44Q34178250-36FBCCDA-7FFC-4230-B880-4BADEC1B7465Q34457797-16024C24-6434-454B-BFDA-C72D640AE7D7Q34459843-BF820EC3-46C0-409D-A025-126727ADA6D5Q34545686-7A090841-F195-464D-9A44-409C96C6EB45Q34629128-E028E91F-ED50-48A8-AFF7-0C6BE0337A43Q34735441-B98894E3-962D-49E6-BF22-A649B38D0ADEQ34801034-2478D7E3-9D93-4774-9A98-A72C0AFB5DE9Q34802752-E3100521-489E-44F9-AF75-F0FC25F4D5B0Q34818048-066B7EEB-0810-4345-83A1-D385F9078804Q35012056-AF375BD3-21DC-4485-9227-97B4F78D9079Q35675602-1E55604B-3E01-4243-9733-5AE6D1940B2AQ35758657-B27A153F-CAB8-4DBD-9A6F-F83CF6C43C04Q35785136-78D59B51-F504-45DB-B334-4E450E2855B0
P2860
A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A prospective study demonstrat ...... ultifocal leukoencephalopathy.
@ast
A prospective study demonstrat ...... ultifocal leukoencephalopathy.
@en
A prospective study demonstrat ...... ultifocal leukoencephalopathy.
@nl
type
label
A prospective study demonstrat ...... ultifocal leukoencephalopathy.
@ast
A prospective study demonstrat ...... ultifocal leukoencephalopathy.
@en
A prospective study demonstrat ...... ultifocal leukoencephalopathy.
@nl
prefLabel
A prospective study demonstrat ...... ultifocal leukoencephalopathy.
@ast
A prospective study demonstrat ...... ultifocal leukoencephalopathy.
@en
A prospective study demonstrat ...... ultifocal leukoencephalopathy.
@nl
P2093
P356
P1433
P1476
A prospective study demonstrat ...... multifocal leukoencephalopathy
@en
P2093
Igor J Koralnik
Jims Jean-Jacques
Marcelo J Kuroda
Norman L Letvin
P304
P356
10.1093/BRAIN/AWH215
P407
P577
2004-06-23T00:00:00Z